Notice Type
Departmental
Renewal of Provisional Consent to the Distribution of a New Medicine Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Danthron 5 mg/mL, poloxamer 40 mg/mL Suspension, oral Regent Laboratories Limited, North Acton, London, England; Universal Products Limited, Lytham, Lancashire, England and Douglas Pharmaceuticals Limited, Mount Wellington, Auckland. Codalax Danthron 15 mg/mL, poloxamer 200 mg/mL Suspension, oral Regent Laboratories Limited, North Acton, London, England; Universal Products Limited, Lytham, Lancashire, England and Douglas Pharmaceuticals Limited, Mount Wellington, Auckland. Codalax Forte Note: This consent is valid for 2 years from 30 July 1998. Dated this 20th day of August 1998. G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.
Publication Date
27 Aug 1998

Notice Number

1998-go6092

Page Number

3032